Merck Ignored Fosamax Femur Injury Warnings, Jury Told

Law360, New York (April 9, 2013, 8:25 PM EDT) -- Merck & Co. on Tuesday faced its first suit claiming femur fractures were caused by its bone drug Fosamax in New Jersey federal court, with attorneys for a New York woman who sustained a femur break saying Merck ignored warnings of the drug’s risks.

In opening statements, attorneys for Bernadette Glynn told an eight-member jury that the evidence would prove the 58-year-old Glynn broke her right femur as a result of taking Fosamax to increase her bone density. Glynn’s is the first case to go to...
To view the full article, register now.

Related

Sections

Case Information

Case Title

GLYNN et al v. MERCK SHARP & DOHME CORP.


Case Number

3:11-cv-05304

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Judge

Joel A. Pisano

Date Filed

September 15, 2011

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.